HOUSE_OVERSIGHT_024902.jpg

742 KB

Extraction Summary

1
People
8
Organizations
1
Locations
4
Events
1
Relationships
2
Quotes

Document Information

Type: Financial research report / market analysis
File Size: 742 KB
Summary

This document is page 86 of a Cowen 'Collaborative Insights' research report dated February 25, 2019, analyzing the cannabis market in Uruguay. It details corporate acquisitions of Uruguayan cannabis and hemp companies (ICC Labs, NettaGrowth, Inverell S.A.) by larger entities (Aurora, Khiron, Auxly) between 2016 and 2019. The document bears a House Oversight Bates stamp, indicating it was part of a document production for a congressional investigation.

People (1)

Name Role Context
Michael Cella Recipient
The report is watermarked as intended for his email address (michael.cella@cowen.com).

Organizations (8)

Name Type Context
Cowen
Financial services firm issuing the report (Cowen Collaborative Insights).
Aurora
Cannabis company that acquired ICC Labs Inc. in 2018.
ICC Labs Inc. (ICC)
Uruguayan fully licensed company acquired by Aurora.
Khiron
Company that acquired NettaGrowth International Inc. in January 2019.
NettaGrowth International Inc.
Company holding a medical cannabis license in Uruguay, acquired by Khiron.
Auxly Cannabis Group
Company that acquired Inverell S.A. in 2018.
Inverell S.A.
Uruguayan hemp cultivator and extractor acquired by Auxly.
House Oversight Committee
referenced in the Bates stamp/footer 'HOUSE_OVERSIGHT_024902'.

Timeline (4 events)

2016
Increase in land cultivating hemp begins in Uruguay.
Uruguay
2018
Aurora acquires ICC Labs Inc.
Uruguay
Aurora ICC Labs Inc.
2018
Auxly Cannabis Group acquires Inverell S.A.
Uruguay
January 2019
Khiron acquires NettaGrowth International Inc.
Uruguay

Locations (1)

Location Context
The country where the cannabis operations, licensing, and acquisitions described are taking place.

Relationships (1)

Michael Cella Employee/Affiliate Cowen
Email address domain @cowen.com listed in watermark.

Key Quotes (2)

"The current licensed companies have already entered agreements with publicly traded cannabis companies."
Source
HOUSE_OVERSIGHT_024902.jpg
Quote #1
"This report is intended for michael.cella@cowen.com. Unauthorized redistribution of this report is prohibited."
Source
HOUSE_OVERSIGHT_024902.jpg
Quote #2

Full Extracted Text

Complete text extracted from the document (1,193 characters)

COWEN
COLLABORATIVE INSIGHTS
February 25, 2019
The current licensed companies have already entered agreements with publicly traded cannabis companies. In 2018, Aurora acquired Uruguayan fully licensed ICC Labs Inc. (ICC) that operates a GMP-certified lab facility, indoor and outdoor grow operations and distributes CBD-based products under the brand BIDIOL. In January 2019, Khiron acquired NettaGrowth International Inc., which gives the company access to one of the two currently held medical cannabis licenses in Uruguay.
The amount of land cultivating hemp increased since 2016 but it not at the commercial scale yet. There are intentions to grow hemp in order to extract CBD for pharmaceutical and nutraceutical uses. Although cultivation of CBD with less than 1% THC is permitted, it is relatively difficult to access CBD products in Uruguay at the moment. In 2018, Auxly Cannabis Group acquired Uruguayan hemp cultivator and extractor Inverell S.A. with plans to develop and distribute CBD products.
[Vertical text on right margin]: This report is intended for michael.cella@cowen.com. Unauthorized redistribution of this report is prohibited.
86
COWEN.COM
HOUSE_OVERSIGHT_024902

Discussion 0

Sign in to join the discussion

No comments yet

Be the first to share your thoughts on this epstein document